| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.009 |